Shield Post-Approval Study Protocol
Guardant Health, Inc. · NCT06880055
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–81 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 3375
- US sites recruiting
- 58
- Study start
- July 14, 2025
- Record last updated
- August 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an average risk population at a second round of testing for individuals between the ages of 45 and 81 at average risk of CRC using colonoscopy as the reference method.
Being studied: Shield Blood Test for colo-rectal cancer Screening
Conditions: Colo-rectal Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Subjects aged 45-81 years at time of consent
- Intending to undergo a standard of care Shield test
- Considered by a physician or healthcare provider as being of 'average risk' for CRC; 'Average-risk' individuals in the context of CRC screening are defined as those who do not have symptoms of CRC and do not have increased risk factors for the disease (i.e., prior diagnosis of CRC, adenomatous polyps, or inflammatory bowel disease; family history of CRC or known hereditary predisposition to CRC).
- Subject agrees to comply with study procedures and associated standard of care assessments.
Exclusion Criteria
- Undergoing colonoscopy for investigation of symptoms
- Personal history of colorectal cancer (CRC), adenomas, or other related cancers
- Family history of CRC, defined as having one or more first-degree relative (parent, sibling, or child) diagnosed with CRC at any age
- Positive result on another colorectal cancer screening method within the last six months, or:
- 12 months for fecal occult blood test (FOBT) or fecal immunochemical test (FIT)
- 36 months for FIT-DNA test
- Personal history of any of the following high-risk conditions for colorectal cancer:
- Inflammatory Bowel Disease (IBD), including chronic ulcerative colitis (CUC) and Crohn's disease
- Familial adenomatous polyposis (FAP)
- Other hereditary cancer syndromes including but not limited to:
- Hereditary non-polyposis colorectal cancer syndrome (HNPCC) or "Lynch Syndrome", Peutz- Jeghers Syndrome, MUTYH Polyposis (MAP), Gardner's Syndrome, Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Cronkhite-Canada Syndrome, Neurofibromatosis and Familial Hyperplastic Polyposis
- Positive Shield test result within the previous 3 years
- History of any malignancy (patients who have undergone surgical removal of skin squamous cell cancer may be enrolled provided the procedure was completed at least 12 months prior to the date of provision of informed consent for the study)
- Known diagnosis of inflammatory bowel disease
- Currently taking any anti-neoplastic or disease-modifying anti-rheumatic drugs (DMARDs)
- Any major physical trauma (e.g., disruption of tissue, surgery, organ transplant, blood product transfusion) within the 30 days leading up to the provision of informed consent
- Known medical condition which, in the opinion of the Investigator, should preclude enrollment into the study
- Participation in a clinical research study in which an experimental medication has been administered or may be administered within the 30 days leading up to providing informed consent or may be administered through the time of colonoscopy
Recruiting US locations
Southeast Valley Gastroenterology Consultants
Chandler, AZ 85224
Site contact: Charles Schron · 480-899-2994 · cmsphoenix@aol.com
Southeast Valley Gastroenterology Consultants
Gilbert, AZ 85297
Site contact: Charles Schron · 480-899-2994 · cmsphoenix@aol.com
Elite Primary Physicians, Inc.
Anaheim, CA 92805
Site contact: Brandon Bonilla · 818-924-4708 · b.bonilla@amicisresearch.com
Alliance Research Institute, LLC
Canoga Park, CA 91304
Site contact: Victor Odogwu · 818-835-9085 · vodogwu@allianceri.org
Amicis Research Center
Granada Hills, CA 91344
Site contact: Tyrone Rosales · 818-924-4708 · tyrone.rosales@amicisresearch.com
Desert Oasis Healthcare Medical Group
Palm Springs, CA 92262
Site contact: Brooke Yates · 760-320-9505 · byates@mydohc.com
Amicis Research Center
Sherman Oaks, CA 91403
Site contact: William Calder · 818-464-4870 · w.calder@amicisresearch.com
Amicis Research Center
Valencia, CA 91355
Site contact: Veronica Macias · 818-639-8822 · veronica.macias@amicisresearch.com
Coral Clinics
Winnetka, CA 91306
Site contact: William Calder · 818-924-4708 · w.calder@amicisresearch.com
Digestive Disease Associates
Branford, CT 06405
Site contact: Lillian Urrutia · 561-453-3215 · Lurrutia@yanuvia.com
Digestive Disease Associates
Branford, CT 06405
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Gastroenterology Consultants of Boca Raton, LLC
Boca Raton, FL 33486
Site contact: Lillian Urrutia · 561-453-3215 · Lurrutia@yanuvia.com
Manuel Espinel MD PA
Delray Beach, FL 33484
Site contact: Kristell Vazquez · 561-501-4646 · kristell.vazquez92@gmail.com
Innova Pharma Research, LLC
Doral, FL 33172
Site contact: Mario Llobet · 305-200-5646 · mllobet@innovapresearch.com
Marisela Gonzalez, MD
Miami, FL 33134
Site contact: Milagros Fernandez · 305-220-3700 · mfernandez@mariselagonzalezmdpa.net
Research Associates of South Florida, LLC
Miami, FL 33134
Site contact: Stephany Moreno · 786-476-8790 · smoreno@researchassociatesfl.com
Florida South Research Phase I-IV, Inc.
Miami, FL 33166
Site contact: Lisbelle Revoredo · 305-418-0847 · Lrevoredo@southfloridatrials.com
Physicians Group of South Florida
North Miami, FL 33181
Site contact: Daniel Wolfson · 305-609-1349 · danielwolfson1126@yahoo.com
NMC Research
Tampa, FL 33607
Site contact: Jose Martinez · 813-374-0568 · jmartinez@nmc-research.com
Digestive Disease Consultants
Bourbonnais, IL 60914
Site contact: Hussain Boxwalla · 708-860-7866 · hboxwalla@avicennaclinical.com
Digestive Disease Consultants
Bourbonnais, IL 60914
Site contact: Hussain Boxwalla · (708) 860-7866 · hboxwalla@avicennaclinical.com
Christie Clinic
Champaign, IL 61822
Site contact: Andrew Bartlett · 217-366-1331 · abartlett@christieclinic.com
GI Solutions of Illinois
Chicago, IL 60631
Site contact: Hussain Boxwalla · 708-860-7866 · hboxwalla@avicennaclinical.com
GI Solutions of Illinois
Chicago, IL 60631
Site contact: Hussain Boxwalla · (708) 860-7866 · hboxwalla@avicennaclinical.com
Digestive Health Services
Downers Grove, IL 60515
Site contact: Hussain Boxwalla · 708-860-7866 · hboxwalla@avicennaclinical.com
Digestive Health Services
Downers Grove, IL 60515
Site contact: Hussain Boxwalla · (708) 860-7866 · hboxwalla@avicennaclinical.com
Gastroenterology and Internal Medicine Specialists (GAIMS)
Lake Barrington, IL 60010
Site contact: Hussain Boxwalla · 708-860-7866 · hboxwalla@avicennaclinical.com
Gastroenterology and Internal Medicine Specialists (GAIMS)
Lake Barrington, IL 60010
Site contact: Hussain Boxwalla · (708) 860-7866 · hboxwalla@avicennaclinical.com
Northshore Center for Gastroenterology (NCG)
Libertyville, IL 60048
Site contact: Hussain Boxwalla · (708) 860-7866 · hboxwalla@avicennaclinical.com
Southwest Gastroenterology (SWG)
Oak Lawn, IL 60453
Site contact: Hussain Boxwalla · 708-860-7866 · hboxwalla@avicennaclinical.com
Southwest Gastroenterology (SWG)
Oak Lawn, IL 60453
Site contact: Hussain Boxwalla Chief Operating Officer/Owner · (708) 860-7866 · hboxwalla@avicennaclinical.com
Northlake Gastroenterology Associates
Covington, LA 70433
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Northlake Gastroenterology Associates
Hammond, LA 70403
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Embassy Research Network
Bloomfield Township, MI 48302
Site contact: Zander Minano · 248-622-4083 · zminano@embassyresearch.com
Quinn Healthcare, PLLC
Ridgeland, MS 39157
Site contact: Khadijra Lockwood · 601-487-6482 · Khadijra.lockwood@roviaclinical.com
Gastroenterology Associates of New Jersey, LLC
Clifton, NJ 07013
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Gastroenterology Associates of New Jersey, LLC
Montclair, NJ 07042
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Gastroenterology Associates of New Jersey, LLC
Ridgewood, NJ 07450
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Gastroenterology Associates of New Jersey, LLC
Wayne, NJ 07470
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Associated Gastroenterologists of Central New York
Camillus, NY 13031
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Syracuse Gastroenterological Associates, P.C.
East Syracuse, NY 13057
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Associated Gastroenterologists of Central New York
Fayetteville, NY 13066
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
NYU Langone
New York, NY 10010
Site contact: Anika Zaman · (212) 686-7500 ext 15745 · anika.zaman@nyulangone.org
Orchard Park Family Practice
Orchard Park, NY 14127
Site contact: Elizabeth Swanson · 716-339-3666 · swanson@circuitclinical.com
GastroCare LI
Valley Stream, NY 11581
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
GastroCare LI
Valley Stream, NY 11581
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
Cary Gastroenterology Associates
Cary, NC 27518
Site contact: Alan Bernegger · 920-472-1093 · abernegger@yanuvia.com
University of North Carolina at Chapel Hill
Chapel Hill, NC 27514
Site contact: Shilpa Karanjit · 919-843-8519 · shilpa_karanjit@med.unc.edu
University of North Carolina at Chapel Hill
Chapel Hill, NC 27599
Site contact: Shilpa Karanjit · 919-843-8519 · shilpa_karanjit@med.unc.edu
University of North Carolina at Chapel Hill
Hillsborough, NC 27278
Site contact: Shilpa Karanjit · 919-843-8519 · shilpa_karanjit@med.unc.edu
US Digestive Health at Blair
Altoona, PA 16602
Site contact: Amanda Bianconi · 814-946-5469 · abianconi@usdhealth.com
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Alexis Winters · 215-349-8222 · alexis.winters@pennmedicine.upenn.edu
Health Living at Pottstown Medical Specialists, Inc
Pottstown, PA 19464
Site contact: Stacy Cowden · 610-858-9174 · scowden@circuitclinical.com
Integrity Advanced Therapeutics, PLLC
Houston, TX 77090
Site contact: Scott Ward · 281-453-2005 · scott.ward@iat.care
Center for Digestive Disease
Shenandoah, TX 77384
Site contact: Melissa Clark · 936-321-5440 · melissa.clark@cddgastro.net
Horizon Clinical Research Group
Tomball, TX 77375
Site contact: Shatabdi Satpathi · 281-803-9960 · shatabdi@horizoncrg.com
Horizon Clinical Research Group
Tomball, TX 77375
Site contact: Shatabdi Satpathi · 281-803-9960 · shatabdi@horizoncrg.com
Tidewater Physician Multispecialty Group Clinical Research
Williamsburg, VA 23188
Site contact: Gabrielle Land · 757-707-3503 · gabrielle.land@tpmgpc.com
Study contacts (from the official record)
- Hannah Oakley · 415-307-2774 · solar@guardanthealth.com
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55